| Certification: | ISO, FDA, HACCP |
|---|---|
| Assay Method: | HPLC |
| Application Form: | Paste, Tablet, Capsule |
| Application: | Food, Health Care Products |
| State: | Powder |
| Extract Source: | Gingko Biloba |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier
Product Name: Gingko Biloba Extract
Botanic Name: Ginkgo biloba L.
Specification: 24.0% Ginkgo-flavone Glycosides, 6.0%Terpenone Lactones (USP/EP/BP/CP)
Test Method:HPLC
Part of used: Leaf
Appearance: Light brown fine powder
| PRODUCT SPECIFICATIONS | ||
| Product Name: | Gingko biloba extract | |
| Botanic Name: | Ginkgo biloba L. | |
| Scientificname(Family/Genus/Species) | Ginkgoaceae/Ginkgo/G.biloba | |
| Part of plant | Leaf | |
| Solvent extraction | 30% water & 70% ethanol | |
| Country of Origin: | China | |
| Excipent | None | |
| ANALYSIS ITEMS | SPECIFICATION | TEST METHOD |
| Appearance | Fine powder | Organoleptic |
| Color | Light brown | Visual |
| Odour & Taste | Characteristic | Organoleptic |
| Identification | Identical to R.S. sample | HPTLC |
| Ginkgo-flavone Glycosides | NLT 24.0% | HPLC |
| Terpene lactones | NLT 6.0% | HPLC |
| Solubility | Smally soluble in water | |
| Hydrocarbons PAHs | ≤ 50 ppb -Reg.UE 1933/2015 | GC-MS |
| Benzo(a)pyren | ≤ 10 ppb -Reg.UE 1933/2015 | GC-MS |
| Radioactivity | ≤ 600 Bq/Kg -Reg. CE 1409/2009 | |
| Apparent density | 0.4-0.7g/ml | |
| Sieve Analysis | 100% through 80 mesh | USP39 <786> |
| Loss on drying | ≤ 5.0% | Eur.Ph.9.0 [2.5.12] |
| Total Ash | ≤ 5.0% | Eur.Ph.9.0 [2.4.16] |
| Lead (Pb) | ≤ 3.0 mg/kg | Eur.Ph.9.0<2.2.58>ICP-MS |
| Arsenic (As) | ≤ 1.0 mg/kg | Eur.Ph.9.0<2.2.58>ICP-MS |
| Cadmium(Cd) | ≤ 1.0 mg/kg | Eur.Ph.9.0<2.2.58>ICP-MS |
| Mercury(Hg) | ≤ 0.1 mg/kg -Reg.EC629/2008 | Eur.Ph.9.0<2.2.58>ICP-MS |
| Heavy metal | ≤ 10.0 mg/kg | Eur.Ph.9.0<2.4.8> |
| Solvents Residue | Conform Eur.ph. 9.0 <5,4 > and EC European Directive 2009/32 | Eur.Ph.9.0<2.4.24> |
| Pesticides Residues | Conform Regulations(EC) No.396/2005 including annexes and successive updates Reg.2008/839/CE | Gas Chromatography |
| Aerobic bacteria(TAMC) | ≤1000 cfu/g | USP39 <61> |
| Yeast/Moulds(TAMC) | ≤100 cfu/g | USP39 <61> |
| Bile-tol.gram- b./Enterobact.: | ≤100 cfu/g | |
| Escherichia coli: | Absent in 1g | USP39 <62> |
| Salmonella: | Absent in 25g | USP39 <62> |
| Staphylococcus aureus: | Absent in 1g | |
| Aflatoxins B1 | ≤ 5 ppb -Reg.EC 1881/2006 | USP39 <62> |
| Aflatoxins ∑ B1, B2, G1, G2 | ≤ 10 ppb -Reg.EC 1881/2006 | USP39 <62> |
Product Introduction:
Ginkgo biloba is one of the world's oldest living tree species. The earliest record of the use of Ginkgo Biloba leaves as a medicine is mentioned in the Chinese Materia Medical Shen Nung Pen Tsao Ching, as an aid for blood circulation and disorders of lungs. They are also used for chilblains and as a wound plaster. With the advent and popularization of antioxidant theory in recent years, Ginkgo biloba has rapidly become one of the most widely used health supplements in the world.
Ginkgo biloba extract can improve cardiovascular and peripheral vascular circulation function, and improve myocardial ischemia.
Ginkgo biloba extract has the function of promoting memory and improving brain function.
Ginkgo biloba extract can also reduce blood viscosity, scavenging free radicals.
Ginkgo biloba extract can reduce lipid peroxidation level, reduce freckles, moisturize the skin, beautiful appearance.
Ginkgo biloba extract contains excellent antioxidant components, fight against the production of free radicals, prevent collagen oxidation.
COMPANY PROFILE
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}